Trial Profile
A Phase I study of SUVN-I6107
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs SUVN I6107 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 05 Sep 2018 New trial record